199 related articles for article (PubMed ID: 31432151)
61. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
[TBL] [Abstract][Full Text] [Related]
62. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
63. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.
Zaidi MR; Okada Y; Chada KK
Cancer Res; 2006 Aug; 66(15):7453-9. PubMed ID: 16885341
[TBL] [Abstract][Full Text] [Related]
64. Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in
Chen CC; You JY; Lung J; Huang CE; Chen YY; Leu YW; Ho HY; Li CP; Lu CH; Lee KD; Hsu CC; Gau JP
Haematologica; 2017 Mar; 102(3):509-518. PubMed ID: 28057739
[TBL] [Abstract][Full Text] [Related]
65. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
[TBL] [Abstract][Full Text] [Related]
66. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
67. HMGA2 is expressed in an allele-specific manner in human lipomas.
Ashar HR; Tkachenko A; Shah P; Chada K
Cancer Genet Cytogenet; 2003 Jun; 143(2):160-8. PubMed ID: 12781451
[TBL] [Abstract][Full Text] [Related]
68. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract][Full Text] [Related]
69. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
70. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity.
Borrmann L; Schwanbeck R; Heyduk T; Seebeck B; Rogalla P; Bullerdiek J; Wisniewski JR
Nucleic Acids Res; 2003 Dec; 31(23):6841-51. PubMed ID: 14627817
[TBL] [Abstract][Full Text] [Related]
71. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
72. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
[TBL] [Abstract][Full Text] [Related]
73. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
[TBL] [Abstract][Full Text] [Related]
74. Repression of HMGA2 gene expression by human cytomegalovirus involves the IE2 86-kilodalton protein and is necessary for efficient viral replication and inhibition of cyclin A transcription.
Shlapobersky M; Sanders R; Clark C; Spector DH
J Virol; 2006 Oct; 80(20):9951-61. PubMed ID: 17005673
[TBL] [Abstract][Full Text] [Related]
75. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma.
Rabban JT; Dal Cin P; Oliva E
Int J Gynecol Pathol; 2006 Oct; 25(4):403-7. PubMed ID: 16990720
[TBL] [Abstract][Full Text] [Related]
76. The FGFR inhibitor PD173074 binds to the C-terminus of oncofetal HMGA2 and modulates its DNA-binding and transcriptional activation functions.
Ahmed SM; Ragunathan P; Shin J; Peter S; Kleissle S; Neuenschwander M; Schäfer R; Kries JPV; Grüber G; Dröge P
FEBS Lett; 2023 Aug; 597(15):1977-1988. PubMed ID: 37259564
[TBL] [Abstract][Full Text] [Related]
77. HMGA2: A Biomarker in Gynecologic Neoplasia.
Wei JJ
J Clin Transl Pathol; 2022; 2(1):3-7. PubMed ID: 35340777
[TBL] [Abstract][Full Text] [Related]
78. E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression.
Fedele M; Pierantoni GM; Visone R; Fusco A
Cell Div; 2006 Aug; 1():17. PubMed ID: 16914062
[TBL] [Abstract][Full Text] [Related]
79. HMGA2 expression in white adipose tissue linking cellular senescence with diabetes.
Markowski DN; Thies HW; Gottlieb A; Wenk H; Wischnewsky M; Bullerdiek J
Genes Nutr; 2013 Sep; 8(5):449-56. PubMed ID: 23881689
[TBL] [Abstract][Full Text] [Related]
80. Lung cancer: A surprising competitor.
McCarthy N
Nat Rev Cancer; 2014 Feb; 14(2):73. PubMed ID: 24457413
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
